BE763298A - Derives de benzylimidazolidinone - Google Patents

Derives de benzylimidazolidinone

Info

Publication number
BE763298A
BE763298A BE763298A BE763298A BE763298A BE 763298 A BE763298 A BE 763298A BE 763298 A BE763298 A BE 763298A BE 763298 A BE763298 A BE 763298A BE 763298 A BE763298 A BE 763298A
Authority
BE
Belgium
Prior art keywords
benzylimidazolidinone
derivatives
benzylimidazolidinone derivatives
Prior art date
Application number
BE763298A
Other languages
English (en)
Inventor
V Gruenman
M Hoffer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BE763298A publication Critical patent/BE763298A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE763298A 1970-02-24 1971-02-23 Derives de benzylimidazolidinone BE763298A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1376970A 1970-02-24 1970-02-24

Publications (1)

Publication Number Publication Date
BE763298A true BE763298A (fr) 1971-08-23

Family

ID=21761656

Family Applications (1)

Application Number Title Priority Date Filing Date
BE763298A BE763298A (fr) 1970-02-24 1971-02-23 Derives de benzylimidazolidinone

Country Status (18)

Country Link
US (1) US3636039A (fr)
JP (1) JPS5421338B1 (fr)
BE (1) BE763298A (fr)
BR (1) BR7101125D0 (fr)
CA (1) CA967163A (fr)
CH (2) CH567483A5 (fr)
DE (1) DE2108438C2 (fr)
DK (2) DK134601B (fr)
FI (1) FI54919C (fr)
FR (1) FR2081537B1 (fr)
GB (1) GB1292768A (fr)
IE (1) IE35283B1 (fr)
IL (1) IL36237A (fr)
NL (1) NL171446C (fr)
NO (1) NO130680C (fr)
SE (1) SE369190B (fr)
YU (1) YU34407B (fr)
ZA (1) ZA711077B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones
US3966758A (en) * 1975-06-16 1976-06-29 Morton-Norwich Products, Inc. Anti-inflammatory 1-(substituted benzyl)-2-imidazolidinones
US4063022A (en) * 1976-11-22 1977-12-13 Morton-Norwich Products, Inc. Antisecretory 2-imidazolidinones
HU179019B (en) * 1978-11-01 1982-08-28 Gyogyszekutato Intezet Process for preparing 4-//3,4-dialkoxy-phenyl/-alkyl/- 2imidazolidinone derivatives
CA1188616A (fr) * 1981-06-11 1985-06-11 Hoffmann-La Roche Limited Preparations pharmaceutiques
WO1987006576A1 (fr) * 1986-04-29 1987-11-05 Pfizer Inc. ANTIDEPRESSEUR INHIBITEUR DE PHOSPHODIESTERASE DE MPA-c INDEPENDANTE DU CALCIUM
US5459145A (en) * 1988-01-19 1995-10-17 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
US5395935A (en) * 1992-05-08 1995-03-07 Pfizer Inc. Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
ATE247655T1 (de) * 1994-12-13 2003-09-15 Euro Celtique Sa Dreifachsubstituierte thioxanthine
WO1996018399A1 (fr) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryle thioxanthines
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
CA2402384A1 (fr) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Inhibiteurs benzyles de pde4
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DK2170930T3 (da) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
ES2664873T3 (es) 2011-03-01 2018-04-23 Synergy Pharmaceuticals Inc. Proceso de preparación de agonistas de guanilato ciclasa C
EP2958577A2 (fr) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Agonistes du recepteur de la guanylate cyclase pour l'utilisation dans l'irrigation du colon
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
KR20220147691A (ko) 2013-08-09 2022-11-03 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH518285A (de) * 1968-05-01 1972-01-31 Hoffmann La Roche Verfahren zur Herstellung von neuen substituierten Benzylimidazolidinonen

Also Published As

Publication number Publication date
DE2108438A1 (de) 1971-09-09
NL171446B (nl) 1982-11-01
FR2081537B1 (fr) 1974-08-23
US3636039A (en) 1972-01-18
DE2108438C2 (de) 1987-02-05
CH567482A5 (fr) 1975-10-15
CA967163A (en) 1975-05-06
NL171446C (nl) 1983-04-05
NO130680B (fr) 1974-10-14
FR2081537A1 (fr) 1971-12-03
NO130680C (fr) 1975-01-22
JPS5421338B1 (fr) 1979-07-30
IE35283B1 (en) 1976-01-07
YU43971A (en) 1978-12-31
IL36237A0 (en) 1971-04-28
IE35283L (en) 1971-08-24
GB1292768A (en) 1972-10-11
DK570075A (da) 1975-12-15
DK134601C (fr) 1977-05-16
FI54919C (fi) 1979-04-10
ZA711077B (en) 1971-10-27
BR7101125D0 (pt) 1973-04-26
CH567483A5 (fr) 1975-10-15
DK134601B (da) 1976-12-06
FI54919B (fi) 1978-12-29
YU34407B (en) 1979-07-10
NL7102324A (fr) 1971-08-26
SE369190B (fr) 1974-08-12
IL36237A (en) 1974-11-29

Similar Documents

Publication Publication Date Title
BE763298A (fr) Derives de benzylimidazolidinone
BE776406A (fr) Derives de piperidine
BE774673A (fr) Derives de phenylalanine
BE763354A (fr) Derives de methylenedioxy-phenyle
BE776514A (fr) Derives de triazolobenzodiazepine
BE771888A (fr) Derives de melamine
BE771513A (fr) Derives de thiopyrimidine
BE774679A (fr) Derives de phenethylamine
BE762595A (fr) Derives de benzocycloheptane-isoquinoleine
BR7100113D0 (pt) Novos derivados de dioscolan
BE773547A (fr) Derives de benzodiazepine
BE765157A (fr) Derives de phenazine
BE765156A (fr) Derives de phenazine
BE765543A (fr) Derives de piperazine
BE770249A (fr) Derives de quinoline
BE770605A (fr) Derives de benzodiazepine
BE764384A (fr) Derives de quinine
BE768689A (fr) Derives de tetrahydropyridine
BE770402A (fr) Derives de thiazole
BE768171A (fr) Derives de phenazine
BE771756A (fr) Derives de triazolobenzadiazepine
BE762793A (fr) Derives de benzodiazepine
BE768169A (fr) Derives de cyclopropane
BE773852A (fr) Derives thienylalkane basiques
BR7106909D0 (pt) Derivados de fenil-alamina

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: F. HOFFMANN LA ROCHE & CIE S.A.

Effective date: 19880228